Open Access

Efficacy and safety of remimazolam vs. propofol for general anesthesia with tracheal intubation: Systematic review and meta‑analysis

  • Authors:
    • Hong Luo
    • Zuolei Tang
  • View Affiliations

  • Published online on: November 15, 2024     https://doi.org/10.3892/br.2024.1891
  • Article Number: 13
  • Copyright: © Luo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Remimazolam is an ultra‑short‑acting intravenous benzodiazepine derivative approved for sedation during gastroscopy and colonoscopy. The present study aimed to compare the safety and efficacy of remimazolam and propofol for general anesthesia with tracheal intubation by meta‑analysis. A comprehensive search was conducted in databases, including PubMed, Embase, Cochrane Library and Web of Science, to identify relevant randomized controlled trials (RCTs). The search period was from the inception of these databases until February 2024. All eligible randomized controlled trials that report at least one outcome of interest were subjected to quality assessment and data extraction by two researchers independently using Review Manager 5.4 software. Data analysis was conducted using R software. A total of 14 RCTs with 1,275 patients were included for meta‑analysis. Compared with propofol, remimazolam significantly reduced incidence of hypotension [odds ratio (OR)=0.31, 95% confidence interval (CI; 0.23, 0.43), P<0.0001], bradycardia [OR=0.06, 95% CI (0.00, 1.20), P=0.06] and injection pain [OR=0.02, 95% CI (0.01, 0.08), P<0.0001] with shorter time to recovery of consciousness (ROC) [mean difference (MD)=5.47 min, 95% CI (‑10.70, ‑0.24 min), P=0.04] but longer time to loss of consciousness [MD=37.01 sec, 95% CI (24.42, 49.60 sec), P<0.0001]. Remimazolam was a safer and more effective alternative to propofol for general anesthesia with tracheal intubation and demonstrated a lower risk of adverse events with shorter time to ROC.
View Figures
View References

Related Articles

Journal Cover

January-2025
Volume 22 Issue 1

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Luo H and Tang Z: Efficacy and safety of remimazolam vs. propofol for general anesthesia with tracheal intubation: Systematic review and meta‑analysis. Biomed Rep 22: 13, 2025.
APA
Luo, H., & Tang, Z. (2025). Efficacy and safety of remimazolam vs. propofol for general anesthesia with tracheal intubation: Systematic review and meta‑analysis. Biomedical Reports, 22, 13. https://doi.org/10.3892/br.2024.1891
MLA
Luo, H., Tang, Z."Efficacy and safety of remimazolam vs. propofol for general anesthesia with tracheal intubation: Systematic review and meta‑analysis". Biomedical Reports 22.1 (2025): 13.
Chicago
Luo, H., Tang, Z."Efficacy and safety of remimazolam vs. propofol for general anesthesia with tracheal intubation: Systematic review and meta‑analysis". Biomedical Reports 22, no. 1 (2025): 13. https://doi.org/10.3892/br.2024.1891